	US 12,304,978 B2
	Biobased materials derived from cyclic monoterpenes
Brandon M. Kobilka, Fishkill, NY (US); Jason T. Wertz, Pleasant Valley, NY (US); Sarah K. Czaplewski-Campbell, Rochester, MN (US); and Eric J. Campbell, Rochester, MN (US)
Assigned to International Business Machines Corporation, Armonk, NY (US)
Filed by International Business Machines Corporation, Armonk, NY (US)
Filed on Jun. 7, 2022, as Appl. No. 17/805,708.
Prior Publication US 2023/0391904 A1, Dec. 7, 2023
Int. Cl. C08F 134/02 (2006.01); C01B 19/00 (2006.01); C01G 45/1214 (2025.01); C07B 33/00 (2006.01); C07C 13/00 (2006.01); C07C 13/20 (2006.01); C07C 49/543 (2006.01)

CPC C08F 134/02 (2013.01) [C01G 45/1214 (2013.01); C07C 49/543 (2013.01); C01B 19/004 (2013.01); C07B 33/00 (2013.01); C07C 13/00 (2013.01); C07C 13/20 (2013.01)]

20 Claims

1. A process, comprising:

generating a cyclic monoterpene derivative, the generating comprising:

oxidizing a cyclic monoterpene to generate a ketone derivative;

oxidizing the ketone derivative to form a lactone derivative; and

epoxidizing the lactone derivative; and

reacting the epoxidized lactone derivative to form a polycarbonate.